Surgery Partners Current Ratio 2013-2024 | SGRY
Surgery Partners current ratio from 2013 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Surgery Partners Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $1.04B | $0.58B | 1.80 |
| 2024-06-30 | $1.01B | $0.55B | 1.84 |
| 2024-03-31 | $0.90B | $0.52B | 1.71 |
| 2023-12-31 | $0.90B | $0.52B | 1.71 |
| 2023-09-30 | $0.88B | $0.50B | 1.75 |
| 2023-06-30 | $0.81B | $0.46B | 1.77 |
| 2023-03-31 | $0.87B | $0.48B | 1.83 |
| 2022-12-31 | $0.92B | $0.49B | 1.87 |
| 2022-09-30 | $0.74B | $0.62B | 1.18 |
| 2022-06-30 | $0.79B | $0.52B | 1.51 |
| 2022-03-31 | $0.94B | $0.54B | 1.73 |
| 2021-12-31 | $0.95B | $0.54B | 1.76 |
| 2021-09-30 | $0.84B | $0.54B | 1.56 |
| 2021-06-30 | $0.95B | $0.53B | 1.79 |
| 2021-03-31 | $1.02B | $0.58B | 1.77 |
| 2020-12-31 | $0.80B | $0.56B | 1.44 |
| 2020-09-30 | $0.89B | $0.59B | 1.51 |
| 2020-06-30 | $0.75B | $0.57B | 1.31 |
| 2020-03-31 | $0.62B | $0.41B | 1.49 |
| 2019-12-31 | $0.53B | $0.40B | 1.32 |
| 2019-09-30 | $0.52B | $0.38B | 1.36 |
| 2019-06-30 | $0.53B | $0.37B | 1.43 |
| 2019-03-31 | $0.54B | $0.36B | 1.49 |
| 2018-12-31 | $0.59B | $0.35B | 1.68 |
| 2018-09-30 | $0.46B | $0.30B | 1.57 |
| 2018-06-30 | $0.47B | $0.30B | 1.59 |
| 2018-03-31 | $0.49B | $0.29B | 1.72 |
| 2017-12-31 | $0.56B | $0.30B | 1.86 |
| 2017-09-30 | $0.57B | $0.28B | 2.09 |
| 2017-06-30 | $0.35B | $0.19B | 1.89 |
| 2017-03-31 | $0.35B | $0.20B | 1.78 |
| 2016-12-31 | $0.36B | $0.19B | 1.94 |
| 2016-09-30 | $0.33B | $0.18B | 1.84 |
| 2016-06-30 | $0.32B | $0.18B | 1.74 |
| 2016-03-31 | $0.40B | $0.18B | 2.15 |
| 2015-12-31 | $0.31B | $0.18B | 1.72 |
| 2015-09-30 | $0.29B | $0.18B | 1.64 |
| 2015-06-30 | $0.00B | 0.00 | |
| 2015-03-31 | $0.00B | 0.00 | |
| 2014-12-31 | $0.00B | 0.00 | |
| 2014-09-30 | $0.00B | 0.00 | |
| 2013-12-31 | $0.08B | $0.04B | 1.94 |
| 2012-12-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $3.273B | $2.743B |
| Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $92.839B | 12.14 |
| Cencora (COR) | United States | $49.468B | 18.60 |
| DiDi Global (DIDIY) | China | $22.650B | 0.00 |
| Natera (NTRA) | United States | $22.209B | 0.00 |
| ICON (ICLR) | Ireland | $16.344B | 14.56 |
| Revvity (RVTY) | United States | $15.033B | 26.11 |
| Avantor (AVTR) | United States | $14.626B | 21.93 |
| BioMerieux (BMXMF) | France | $14.203B | 0.00 |
| Viatris (VTRS) | United States | $13.523B | 4.17 |
| CochLear (CHEOY) | Australia | $12.916B | 0.00 |
| Solventum (SOLV) | United States | $12.870B | 0.00 |
| Doximity (DOCS) | United States | $10.767B | 63.37 |
| Medpace Holdings (MEDP) | United States | $10.662B | 30.04 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.135B | 0.00 |
| HealthEquity (HQY) | United States | $9.429B | 47.30 |
| Sonic Healthcare (SKHHY) | Australia | $8.657B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.266B | 15.97 |
| Bausch + Lomb (BLCO) | Canada | $6.301B | 29.31 |
| Amplifon S.p.A (AMFPF) | Italy | $6.136B | 31.28 |
| BrightSpring Health Services (BTSG) | United States | $4.136B | 87.96 |
| Organon (OGN) | United States | $4.079B | 4.11 |
| Sotera Health (SHC) | United States | $3.875B | 20.73 |
| Concentras Parent (CON) | United States | $2.998B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.937B | 0.00 |
| Premier (PINC) | United States | $2.191B | 11.40 |
| Ardent Health Partners (ARDT) | United States | $2.098B | 0.00 |
| PACS (PACS) | United States | $2.080B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.079B | 0.00 |
| Progyny (PGNY) | United States | $1.980B | 40.09 |
| GoodRx Holdings (GDRX) | United States | $1.845B | 48.40 |
| Teladoc Health (TDOC) | United States | $1.782B | 0.00 |
| Agilon Health (AGL) | United States | $1.413B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.219B | 11.92 |
| CareDx (CDNA) | United States | $1.210B | 0.00 |
| Embecta (EMBC) | United States | $1.070B | 7.48 |
| AMN Healthcare Services Inc (AMN) | United States | $1.036B | 7.02 |
| Establishment Labs Holdings (ESTA) | $0.947B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.637B | 0.00 |
| SBC Medicals (SBC) | United States | $0.518B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.505B | 0.00 |
| DocGo (DCGO) | United States | $0.490B | 18.46 |
| QDM (QDMI) | Hong Kong, SAR China | $0.480B | 12.56 |
| Sonida Senior Living (SNDA) | United States | $0.451B | 0.00 |
| Enhabit (EHAB) | United States | $0.422B | 36.52 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.280B | 0.00 |
| MultiPlan (MPLN) | United States | $0.267B | 0.00 |
| LifeMD (LFMD) | United States | $0.248B | 0.00 |
| Nutex Health (NUTX) | United States | $0.243B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.212B | 0.00 |
| Beauty Health (SKIN) | United States | $0.205B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.184B | 0.00 |
| Biodesix (BDSX) | United States | $0.151B | 0.00 |
| So-Young (SY) | China | $0.105B | 17.83 |
| Ascend Wellness Holdings (AAWH) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.068B | 0.00 |
| ModivCare (MODV) | United States | $0.066B | 3.57 |
| Oncology Institute (TOI) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 1.61 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| OncoCyte (OCX) | United States | $0.034B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.024B | 0.00 |
| KindlyMD (KDLY) | United States | $0.008B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |